ADH5 and cystic fibrosis: Some previous reports propose the use of NO-donors (such as S-nitrosoglutathione, GSNO) or the inhibitors of GSNO-reductase (GSNOR), in controlling airway inflammation in experimental allergic asthma (Blonder et al., 2014) and CF models (Zaman et al., 2006, 2014, 2016; Rafeeq and Murad, 2017).